QNTM
Price
$23.70
Change
+$0.23 (+0.98%)
Updated
Aug 1 closing price
Capitalization
81.09M
RGC
Price
$12.97
Change
-$1.46 (-10.12%)
Updated
Aug 1 closing price
Capitalization
50.75M
Interact to see
Advertisement

QNTM vs RGC

Header iconQNTM vs RGC Comparison
Open Charts QNTM vs RGCBanner chart's image
Quantum Biopharma
Price$23.70
Change+$0.23 (+0.98%)
Volume$131.88K
Capitalization81.09M
Regencell Bioscience Holdings
Price$12.97
Change-$1.46 (-10.12%)
Volume$369.42K
Capitalization50.75M
QNTM vs RGC Comparison Chart in %
Loading...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QNTM vs. RGC commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNTM is a Hold and RGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (QNTM: $23.47 vs. RGC: $13.20)
Brand notoriety: QNTM and RGC are both not notable
QNTM represents the Biotechnology, while RGC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: QNTM: 33% vs. RGC: 18%
Market capitalization -- QNTM: $81.09M vs. RGC: $50.75M
QNTM [@Biotechnology] is valued at $81.09M. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNTM’s FA Score shows that 0 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • QNTM’s FA Score: 0 green, 5 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, both QNTM and RGC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNTM’s TA Score shows that 3 TA indicator(s) are bullish while RGC’s TA Score has 3 bullish TA indicator(s).

  • QNTM’s TA Score: 3 bullish, 3 bearish.
  • RGC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, QNTM is a better buy in the short-term than RGC.

Price Growth

QNTM (@Biotechnology) experienced а -1.51% price change this week, while RGC (@Pharmaceuticals: Other) price change was -13.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.53%. For the same industry, the average monthly price growth was +4.44%, and the average quarterly price growth was +79.95%.

Reported Earning Dates

QNTM is expected to report earnings on May 14, 2025.

RGC is expected to report earnings on Jun 30, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-2.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNTM($81.1M) has a higher market cap than RGC($50.8M). RGC YTD gains are higher at: 9876.844 vs. QNTM (544.022). RGC has higher annual earnings (EBITDA): -4.67M vs. QNTM (-20.68M). QNTM has more cash in the bank: 3.54M vs. RGC (306K). QNTM has less debt than RGC: QNTM (1.28M) vs RGC (3.54M). QNTM (0) and RGC (0) have equivalent revenues.
QNTMRGCQNTM / RGC
Capitalization81.1M50.8M160%
EBITDA-20.68M-4.67M443%
Gain YTD544.0229876.8446%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.54M306K1,157%
Total Debt1.28M3.54M36%
FUNDAMENTALS RATINGS
QNTM vs RGC: Fundamental Ratings
QNTM
RGC
OUTLOOK RATING
1..100
1186
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNTM's Valuation (75) in the null industry is in the same range as RGC (95) in the Movies Or Entertainment industry. This means that QNTM’s stock grew similarly to RGC’s over the last 12 months.

QNTM's Profit vs Risk Rating (100) in the null industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that QNTM’s stock grew similarly to RGC’s over the last 12 months.

QNTM's SMR Rating (99) in the null industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that QNTM’s stock grew similarly to RGC’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as RGC (34) in the Movies Or Entertainment industry. This means that QNTM’s stock grew similarly to RGC’s over the last 12 months.

QNTM's P/E Growth Rating (100) in the null industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that QNTM’s stock grew similarly to RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNTMRGC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCKL12.000.97
+8.79%
Freddie Mac
BOWFF52.170.17
+0.33%
Boardwalk Real Estate Investment Trust
GBLBF87.70N/A
N/A
Groupe Bruxelles Lambert SA
NTNOF0.56N/A
N/A
NORTHERN OCEAN LTD
GFGSF0.10-0.01
-5.65%
GFG Resources Inc.

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+0.98%
HYPD - QNTM
34%
Loosely correlated
-14.29%
AZTR - QNTM
29%
Poorly correlated
-2.92%
CPIX - QNTM
26%
Poorly correlated
+2.03%
RNA - QNTM
26%
Poorly correlated
-2.15%
EBS - QNTM
24%
Poorly correlated
-4.25%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and QNTM have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
-10.12%
QNTM - RGC
21%
Poorly correlated
+0.98%
SBFM - RGC
20%
Poorly correlated
-2.08%
ANIP - RGC
11%
Poorly correlated
+0.92%
PCRX - RGC
11%
Poorly correlated
+4.65%
CPIX - RGC
8%
Poorly correlated
+2.03%
More